Acacia Research Corp
NASDAQ:ACTG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.62
5.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Acacia Research Corp
You don't have any saved screeners yet
Good day, and welcome to the Acacia Research First Quarter 2024 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to Rob Fink. Please go ahead.
Thank you, operator. Thank you, everyone, for joining us today. Hosting the call today are MJ McNulty, Chief Executive Officer; and Kirsten Hoover, Interim Chief Financial Officer. Before beginning, I'd like to remind you that the information provided during this call may contain forward-looking statements relating to current expectations, estimates, forecasts and projections about future events that are forward-looking as defined in the Private Securities Litigation Reform Act of 1995.
These forward-looking statements generally relate to the company's plans, objectives and expertise for future operation and are based on the current estimates and projections, future results or trends. Actual results may differ materially from those projected as a result of certain risks and uncertainties. For a discussion of such risks and uncertainties, please see the risk factors as described in Acacia's annual report on Form 10-K and quarterly reports on Form 10-Q, both of which are filed with the SEC.
I would also like to remind everyone that a press release disclosing the financial was issued this afternoon just after the close of market. The release may be accessed on the company's website under the Press Release section of the Investor Relations tab at acaciaresearch.com.
With all that said, I'd now like to turn the call over to MJ. MJ, the call is yours.
Thanks very much, Rob. In the short time since our last call, we've continued to execute on our capital allocation strategy. We've realized gains from our IP monetization business and cash flows from Printronix, and have deployed capital into our new oil and gas business. Our focus continues to be twofold: first, growing cash flow and earnings from our current businesses; and second, continuing to evaluate opportunities to acquire new businesses into our platform.
Our team has been busy identifying opportunistic situations where our research execution and operating partners can drive attractive earnings and book value per share growth. As it relates to the specifics, in terms of sources of capital, our IP monetization business generated $13.6 million in growth settlements and patent license agreements in the first quarter. These agreements further bolster our position to pursue additional licensing agreements and settlements and our teams advancing discussions with other potential licensees.
The WiFi 6 patent portfolio continues to represent a lucrative opportunity for periodic cash rents, and we believe there's significant incremental value in these patents. Additionally, we continue to evaluate potential additional capital investment into this business to acquire new when we believe there are attractive risk-reward opportunities.
Also, as you will recall, Acacia acquired Printronix operating business in October of 2021. At the time we acquired the business, we believed it represented an attractive price relative to the cash flow able to be generated and recognize there would be some level of operational and strategic restructuring required. Beginning in early 2023, this team began the detailed work of putting the restructuring in motion by replacing the Printronix management team and bringing an operating adviser into the business to formulate and execute on continuous improvement and efficiency initiatives, including significant cost rationalization. These initiatives are bearing fruit. We've now transitioned Printronix from consuming approximately $3.8 million in cash in the LTM period ended March 31, 2023, to generating approximately $6.8 million in cash during LTM period ending March 31, 2024. We further defined and implemented the business' value proposition and go-to-market strategy for both printers and our high-margin consumables business. We're pleased with the progress of Printronix and believe its dual hardware and consumables business model, combined with its streamlined operating structure represent a nice source of cash flow for Acacia.
Turning to our capital allocation initiatives. Early in the second quarter, Benchmark, our oil and gas business unit closed its first significant acquisition, purchasing an attractive group of assets in Texas and Oklahoma. With the closing of the new acquisition now behind us, our experienced team at Benchmark has begun implementing its operational improvement plan. As we've stated previously, operational improvements are a meaningful part of our strategy. Our goal is to acquire mature, long-lived assets and deploy various field enhancements, including artificial lift optimization, a more active well maintenance program and reopening previously closed wells. Benchmark's core strategy of improving the production and efficiency of its assets to maximize cash flow. As a reminder, this acquisition significantly expands the Benchmark portfolio adding approximately 140,000 net acres to approximately 470 operated producing wells in the Western Anadarko Basin throughout the Texas Panhandle and Western Oklahoma, including meaningful exposure to the emerging Cherokee development play via both operated acreage and nonoperated arrangements with best-in-class operators.
As we mentioned before, we like these assets because of their liquids-rich nature, being predominantly oil-based with a production base of approximately 6,000 barrels of oil equivalent per day, exhibiting a low decline profile. Kirsten will discuss the financial results for Benchmark specific to the first quarter before we close the transaction. And I would highlight that in our next earnings, you should begin to see the significant benefits we expect from the platform in terms of revenue and free cash flow generation. We expect the consolidated Benchmark entity to generate approximately $50 million in asset-level cash flow over the next 12 months at current strip pricing. As a reminder, Acacia owns 73.5% of Benchmark Energy pro forma for the transaction.
Consistent with our risk management approach upon closing, Benchmark implemented hedges for over 70% of its operated oil and gas production for the next 3 years at attractive price levels, protecting a significant portion of the returns we've underwrote when we signed a deal in February. With Benchmark's additional scale, we've been able to bring on additional hedging counterparties that not only help us achieve the best pricing, but also allow us to diversify risk.
Taking this acquisition into account, Acacia has approximately $400 million in capital to deploy into new acquisitions. We believe the oil and gas business represents an attractive complement to our acquisition initiatives in industrials, technology and health care, where we also continue to evaluate operating businesses to add to our portfolio. Overall, the M&A environment is encouraging for the Acacia strategy, and we're seeing a strong pipeline of both public and private opportunities that fit well within our desired characteristics.
While Acacia is less reliant on leverage for returns in our financial buyer counterparts, the lending environment appears to be opening up, and we have seen traditional banks starting to reemerge after being on the sidelines for the last year. This will allow us to be opportunistic in utilizing leverage as we evaluate total cost of capital in each acquisition we make.
In the public markets, valuations generally remain elevated, we're searching for and finding opportunities that are not well understood or where we believe our ownership can unlock significantly more value. We're continuing to see more situations where the market is creating attractive opportunities for buyers willing to do the fundamental work to understand the situation and find value. As a result of these activities this quarter, our book value per share at March 31, 2024, was $5.89 per share compared to $5.90 per share at December 31, 2023. Excluding an additional accrual of $6.2 million related to the AIP Matter, which is discussed in greater detail in our 10-Q, our adjusted book value per share on March 31, 2024, would have been $5.95 a share. As a reminder, the AIP Matter relates to an ongoing legal matter involving a profits interest plan adopted by prior members of management and the Board in 2017. The profits interest plan granted a profit interest in Veritone 10% warrants certain members of management and the Board has compensation for services rendered. Importantly, those members of management and the Board separated from Acacia in 2018 and 2019 and the Veritone 10% warrants were exercised in 2020 and 2021.
As we mentioned before, book value per share is a metric we follow closely and is the primary metric on which our team's compensation is based. We believe this creates very close alignment with our shareholders.
Finally, I'd like to note that the Board of Directors has nominated Michelle Felman, an accomplished executive with more than 3 decades of experience in real estate, finance and investing to serve as an independent director for the election at the company's Annual Meeting of Stockholders to be held on May 21, 2024. Michelle is set to fill the vacancy left by Catherine who has served as an independent director since January 2019, and is was not standing for reelection for a term which is set to expire at the annual meeting. I'd like to thank Catherine for her service to Acacia during a period of transition. Her voice and counsel have been invaluable, and on behalf of Acacia and our shareholders, I'd like to express our gratitude.
Ms. Polman brings strong Board and operating expertise to Acacia, having served on several public and private company boards. She currently serves on the Board of Directors of Cushman & Wakefield sharing the Nominating and Governance Committee and serving as a member of the Compensation Committee. In addition, she recently completed her term as an advisory director at Investcorp, a leading provider and manager of alternative investment products. She also served as a trustee of the Partners Group, a global private equity firm, where she was Chair of the Investment Oversight Committee and a member of the Audit Committee and the Compensation and Governance Committee. More on Ms. Felman's impressive background and experience can be found in our proxy materials located in the filings and Financial section of our website. We're confident that Ms. Felman's deep and relevant industry expertise as well as their experience on public company boards will be invaluable to Acacia going forward.
I'd now like to turn the call over to Kirsten to discuss our first quarter results.
Thank you, MJ. Our GAAP book value at March 31, 2024, was $589.6 million or $5.89 per share. Excluding the impact of the additional accrual of $6.2 million related to the AIP Matter, MJ discussed earlier, our book value per share at March 31, 2024, would have been $5.95 per share. Printronix generated $2.8 million in cash during the quarter, reflecting the changes and process improvements to optimize operational efficiencies that have taken place over the past year. We expect Printronix to continue to generate free cash flow on an annual basis. Benchmark's operating income during the quarter was $0.2 million, which included $0.4 million of noncash depreciation, depletion and amortization, and does not reflect $0.8 million of realized derivative gains.
Now let me turn to the first quarter results. Total revenues were $24.3 million compared to $14.8 million in the same quarter last year. Let me break this down between our operating segments. The intellectual property business generated $13.6 million in licensing and other revenue during the quarter compared to $4.2 million in the same quarter last year, reflecting an increase in the number of license agreements executed quarter-over-quarter and higher average license fees. Printronix, our industrial operations business, generated $8.8 million in revenues during the quarter compared to $10.6 million in the same quarter last year. Benchmark, our energy operations, which we acquired on November 13, 2023 generated $1.9 million in revenue in the quarter, which excludes gains on hedging contracts of $0.8 million. As a reminder, in April, we closed Benchmark's first acquisition following Acacia's initial investment. Results from this acquisition will be reported beginning in our second quarter. Pro forma for the acquisition, we will own 73.5% of this subsidiary.
General and administrative expenses were $12.4 million compared to $12 million in the same quarter of last year, with the increase due to the increase in variable performance-based compensation costs for the intellectual property segment, partially offset by a decrease in parent legal fees and a decrease in Printronix G&A. Operating loss was $2.1 million compared to an operating loss of $9.3 million in the same quarter of last year, with the decrease due to higher revenues generated in the IP business. Printronix contributed $1.2 million in operating income, which included $0.7 million of noncash depreciation and amortization expense. Benchmark contributed $0.2 million in operating income, which included $0.4 million in noncash depreciation and depletion expense.
GAAP net loss attributable to Acacia Research Corporation was $0.2 million or $0.00 per share compared to GAAP net income attributable to Acacia of $9.4 million or a loss of $0.07 per diluted share in the first quarter of last year. Diluted earnings per share adjust the numerator used in the basic earnings per share computation for the fair value adjustments on warrant and embedded derivative liabilities resulting in a diluted net loss attributable to common stockholders.
Excluding the impact of the additional accrual relating to the AIP matter, which represented $0.06 earnings per share, our earnings per share for the first quarter of 2024 would be $0.06 per share. As of March 31, 2024, our NOL totaled approximately $18 million. We will continue to evaluate the most efficient ways to maximize this asset.
Turning now to the balance sheet. Cash, cash equivalents and equity securities at fair value totaled $461.7 million at March 31, 2024, compared to $403.2 million at December 31, 2023. Equity securities without determinable fair value totaled $5.8 million at March 31, 2024, unchanged from December 31, 2023. Investment securities, representing equity method investments net of noncontrolling interest, totaled $19.9 million at March 31, 2024, unchanged from December 31, 2023. Acacia owns 64% of MalinJ1, which results in a 26% ownership stake in Viamet Pharmaceuticals for Acacia. The company currently carries no parent debt, having paid off its senior secured notes on July 13, 2023, and $13 million in nonrecourse debt at Benchmark as of March 31, 2024. We continue to believe that cash per share is an important metric for measuring our progress. As of March 31, 2024, our cash per share stood at $4.39 per share. More details on these results have been made available in the press release that was issued this afternoon and in our quarterly report on Form 10-Q, which we will file with the SEC later today.
With that, we'd be pleased to take your questions.
[Operator Instructions] Your first question is coming from Brett Reiss with Janney Montgomery Scott.
I just have a couple of questions to get my arms around the Benchmark. So we basically have laid out $67 million for the 73.5% interest we have in it. Do we value it or mark it at $67 million. I'm just wondering why the book value after this investment did not move up?
Yes. So that's a great question, Brett. So it is valued, well, 2 points. The $67 million for the second acquisition of Benchmark. Remember, the first we made in November, and we invested roughly $10 million for half the company is market cost. The second investment, which is the much larger of the two, which we closed this year was actually closed in April. So it's not yet reflected in the numbers because it wasn't first quarter event, but you'll see that -- you'll start to see that in the second quarter. But broadly, how we think about it when you do see it in the second quarter is we're taking cash and we're investing it into those assets. And with those assets marked at cost, there's a little bit of expense that goes against it for deal-related expenses. You shouldn't see a material appreciation of book value because you're trading cash for an asset. So you're just moving around the asset side of the balance sheet.
Okay. I appreciate that. Now somewhere in my notes at the Benchmark company level, it was anticipated or expected to generate $45 million in EBITDA or cash -- operating cash flow. Do you recall this number?
Yes. That's what we mentioned on our last call, it was cash flow at the asset level, which is effective
All right. So we're entitled to 73.5% of that $45 million. And then what we don't know is what the SG&A on Benchmark is going to be. I'm just trying to get a handle on what -- or maybe you can just short cut it. I mean what do we own with Benchmark so we can begin to feel -- get a sense of valuation.
Yes. So we own -- with Benchmark, we are in a company called Benchmark. Benchmark owns two assets. They own the first asset that we bought half of, and they own the second asset, which we closed subsequent to the end of the quarter, which pro forma for our investment and our partner's equity investment into that, we will own 73.5% of the combination of those 2 assets, which is roughly together on a pro forma basis, $50 million of earnings, of which 73.5% would be net to our stake.
Okay. Now that's aspirational the $50 million in earnings. How long do you think it will take to gear up to achieve that?
So you're not going to see it all in '24 because we closed the larger of the 2 acquisitions in April. That is at current oil and gas prices. And recall, we're hedged 3 years out, 70% on the strip. And so you'll start to see those numbers go through on a monthly basis. They will ramp because they'll come into our financial statements on a monthly and quarterly basis. But the company is running at that level of earnings today.
Right. And so monthly -- well, 0.735 x 50 million divided by 12. I mean eventually, we're going to see $2.5 million, $3 million of cash flow come to us from this investment.
Every month, you'll see a quarterly rent. But yes, every month, that's roughly the amount of cash flow that will be generated in this investment.
Why don't you do some more of this stuff.
Well, look, I mean that's -- we joke and laugh about it, but those are the types of opportunities that we're looking for. And so our strike zone is very tight in terms of risk management and risk reward. And we do not want to be an oil and gas company. We want to have a diversified portfolio, but we're looking at other opportunities in other industries where the profile is [indiscernible]. And so those are the types of acquisitions that we're looking to add into our portfolio.
Right, right. Now one last one, a little change in direction. Last conference call, you mentioned strong pipeline of opportunities outside oil and gas. Another quarter has passed, and we've not seen to pull the trigger on any of it. And then you said earlier in your comments, deals and bank credit is loosening up. Does this make it more likely you can get a deal or less likely?
Look, the way I would answer that question is to say that we're not looking to buy companies for the sake of buying companies. We're looking to buy companies where we can have a really nice risk/reward profile associated with them, and the volume of M&A will be dictated by the types of opportunities we see. We are seeing a lot of things that are quite interesting right now. We are looking at things that are off the run. We're looking at things that others don't understand. And in these types of transactions, we have counterparties and we need to negotiate to a point where both counterparties are willing to transact. And that's our job is to find those opportunities and get to a point where we can transact at a price and on terms that are attractive to our shareholders. And so we're not looking to do an acquisition a month. We're looking to do an acquisition when that acquisition makes sense collectively for all of us to preserve and grow our capital base.
Right. One last one. It's the macroeconomic backdrop, is this to soft landing, or on the alternative, we have a hard landing, would a hard landing make it more likely you can get a deal outside of oil and gas done?
I don't think it hurts, and it really just depends on the particular companies that we are seeing that we like and think there's opportunity in, and who owns the companies and what the situation is. But we're not looking to make macro-related bets. If we have a hard landing, historically, that has been a very good time to buy companies if you have conviction around the cycle. And so we are not calling the macro picture. We're not waiting for a recession. We're not assuming that the market will continue to be in a goldilocks phase indefinitely. It's really a -- it's a case-by-case situation. And as I mentioned earlier, each of the companies that we're looking at is very idiosyncratic.
[Operator Instructions] Your next question is coming from a private investor, Ron Heller.
Can you go through the cash on the balance sheet again. I think we went from $400 million, and I've heard two numbers, $439 million and $460 million. Can you clarify that?
Yes, Kirsten, do you want to take that one?
So yes, the 439 is our cash and cash equivalents as of the end of March. And then the 460 includes our cash and equity securities.
And it is up from the previously reported $400 million. Can you tell me what the delta is on that?
Sure. We had some receivables as of the end of December from our IP group that were all collected in the quarter. That was really the biggest driver of the increase. Sorry -- and also, as we mentioned, in the fourth quarter, we recorded an unrealized gain on our Arix investment for the forward sale contract that we had, that closed also in the quarter and turned to cash.
Yes. So Rod, if you take the December 31 cash number, add the cash receipts from the intellectual property business and the Arix sale, which moved from a marketable security to cash with a slight gain associated to the 12/31 marketable security number when we actually converted it into cash. That's how you get to the numbers that Kirsten is talking about. And then the other number that I mentioned is pro forma for the funding of the second Benchmark acquisition. We'll have approximately $400 million of cash and securities, liquid marketable securities that we can use to go deploy into other acquisitions.
Okay. Two more questions. Back in November of 2023, the company announced a buyback of stock, no obligation to buy stock back, but I think it was $20 million not to exceed 5 million shares. Has the company bought any stock back to date?
We have not bought any stock back here, Rob.
Okay. And -- did the company intend to buy stock back back when they made the announcement in the fourth quarter? And if so, why hasn't the company bought any stock back considering it's been, in some cases, a 30% discount to book value.
I appreciate you asking the question. We're evaluating it on a consistent basis. And we're seeing a lot of opportunities to deploy cash into acquisitions. So we -- when we think it's opportunistic, we'll buy stock back. And if we don't think it's opportunistic, or it's less opportunistic than making acquisitions, then we use cash to make acquisitions.
One footnote question regarding the lot of time and releases time and conversation with CC in the release has been on book value per share. And is my math correct that if you did buy stock back or any company bought stock back at a significant discount that it would, by definition, increase book value per share?
As a general theory, yes, that is correct. The magnitude of which this buyback increases book value per share is attractive. But again, we have attractive ways to deploy the capital.
Your next question is coming from Adam Egleston with Formidable Asset Management.
the punch on the buyback question, but would love to hear little bit more or just echo the sentiment about that being the cost of capital, so to speak, that's the way you and the Board are looking at it. In terms of the legacy, you don't talk much about those. The sort of at this point. Any impetus by management to divest those or do something with them? Is there a market out there for those assets?
Yes. I appreciate you asking the question. And you're right, we didn't mention it in the transcript. I would use the term noncore as opposed to orphan maybe because we do work those assets pretty hard. And hence, the goal is to create liquidity on those assets. And as you know, there are two biotech companies, the overwhelming majority of the value there is to biotech companies, and we are actively working to create liquidity in those positions.
Got it. Great. And that's a good segue actually as we think about the market opportunities out there. You mentioned biotech, and there's clearly a lot of carnage in that space. Is there any opportunity in that orphan biotech space? And again, apologies for the term. But with regards to some publicly traded biotech that are sub cash, et cetera, or is that one of those we kind of too hard back as you think about the public market opportunity?
I mean I think the answer to the question is a little bit in between the two kind of goalposts you put out there. I would say in the past, we have evaluated some of the net debts in the pharmaceutical world. One of the issues is without control, you can't really affect the change or the trajectory of the cash burn, which gives us a little bit ARPR. And then with the control, you're effectively taking technology risk, and that's not really the business that we've set out to be in. We're looking for companies with durable earnings. And so there is potential alpha in those names. I'm candidly not sure that we're the right people with the right folks on staff and experience to be able to pick that horse. And so while it is a learning from a valuation standpoint for us, we don't know. We're not exactly sure how we create value out of those opportunities as opposed to just betting on horses.
Your next question is coming from Todd Selter with 88 Management.
Congratulations on a solid quarter. Quick question. When I look at the income statement, we're sitting with $400 million large. And I know T-bills and money market accounts are yielding in the area of 5%, which should generate somewhere around $5 million a quarter. Where do we see any income generated from our liquidity on our income statement?
Kirsten, do you want to take that one?
Yes. You'll see that in the other operating or other income and expense and there's a line interest income and other is $4.9 million for the quarter.
Great. Okay. Appreciate that, Kirsten. Okay. MJ, keep up the good work with the team. We appreciate you.
There appears to be no further questions in queue at this time. I would now like to turn the floor back over to MJ for any closing remarks.
Thanks for everyone's participation here today. Thanks for paying attention. And we appreciate the questions and the conversations. And most importantly, we appreciate the idea flow that we get from you all because we're -- you're an investor in us, but we're all in the same business in certain ways. And so we love to hear the ideas that come our way from you all, and we'll talk to you next quarter.
Thank you, everyone. This does conclude today's conference call. You may disconnect your phone lines at this time, and have a wonderful day. Thank you for your participation.